ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits

April 29, 1977

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977